Aro Biotherapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
170 S Independence Mall W Ste 740, Phila...Phone Number
(215) 544-1175Website
www.arobiotx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Aro Biotherapeutics
Based out of Philadelphia, PA, Aro Biotherapeutics is a biotechnology company with a focus on tissue-targeted genetic medicines.Explore more
Aro Biotherapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aro Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aro Biotherapeutics had a recent Job posting/layoffs
Check out if Aro Biotherapeutics is spiking on competitors!
Check if Aro Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aro Biotherapeutics
Earning: See what the market has to say on Aro Biotherapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Aro Biotherapeutics has new funding data
Website visits: Recent activity has been detected on your website
Aro Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aro Biotherapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aro Biotherapeutics
Compare insights from companies similar to Aro Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
Aro Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aro Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aro Biotherapeutics.
Aro Biotherapeutics financials insights
Gather financial insights about Aro Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$88M
2023
Series B
$41.5M
Aro Biotherapeutics Tech Stack
A closer look at the technologies used by Aro Biotherapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Funding
Aro Biotherapeutics News & Media
Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer
PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, targeted short-interfering RNA (siRNA) medicines, today announced that its co-founder, Susan Dillon, Ph.D., will transition from her position as president and chief executive officer (CEO) and continue as chair of the Board of Directors and advisor to the company. As part of the planned leadership transition, Aro appointed industry veteran Purnanand Sarma, Ph.D., as the CEO andAro Biotherapeutics Announces U.S. FDA Clearance of IND Application for ABX1100 for Potential Treatment of Late-Onset Pompe Disease (LOPD)
PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced that it has received U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug Application (IND) for ABX1100, a novel therapy currently being investigated in a phase 1 study in late-onset Pompe disease (LOPD) patients. Additionally, Aro will present data at the 2025 WORLDSymposium™ in San Diego, Calif., from aAro Biotherapeutics Doses First Patient in Phase 1b Trial of ABX1100 in Late-Onset Pompe Disease (LOPD)
PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced the dosing of the first patient in its clinical trial of ABX1100, a novel treatment for late-onset Pompe disease (LOPD). “We are excited to initiate dosing in the Phase 1b trial, the results of which should provide the first proof of concept for GYS1 inhibition as a therapeutic strategy in Pompe disease,” said Susan Dillon, Ph.D., coAro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer
PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today announced the appointment of Glenn D. Crater, MD, as chief medical officer (CMO). Dr. Crater will lead the development of Aro’s pipeline of Centyrin-based, tissue-targeted medications, including the company’s lead product candidate ABX1100, a novel potential treatment for Pompe disease. “Dr. Crater joins our team at an opportune time, with our le
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aro Biotherapeutics
Sign Up For FreeTo access detailed company insights
Based out of Philadelphia, PA, Aro Biotherapeutics is a biotechnology company with a focus on tissue-targeted genetic medicines.... Read More
